S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7230 −0.30%
CLOSED · 17:25 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

APTX

Apotex Health Corp.
TSX · HEALTH CARE · LIFE SCIENCES
33.63
+0.61 +1.85%
CAD · Sep 6, 01:19 a.m. ET

One year, everything drawn on

61 SESSIONS · DAILY CLOSES
41363126JUN 2026JUL
Insider buyInsider sellHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-09-06
Shorts (latest report): 1M short · +85K last period
Street (tracked calls): 1 scored · avg −10.4 pts vs index
Every line of the math
24FLAG

Insider activity

No open-market insider filings on APTX in the imported SEDI data.

Short interest

HISTORY
ReportShares shortChange
2026-08-311M+85K
2026-08-15927K+252K
2026-07-31676K+452K
2026-07-15224K−98K

Calls on APTX

SCORED VS INDEX
WhoThe callCalledReturnVs index
Brian MaddenPicked recently-IPO'd Apotex Health, projecting roughly 20% Canadian market share in generic semaglutide as Canada's largest pharma manufacturer.logged from a dated source2026-08-07 · $37.38−10.0%−10.4 behind
Watch APTX. Know when insiders buy.
One email the day a filing lands. Free.